On the occasion of World Cancer Day 2024; focus on hypertension and anti-cancer agents

被引:0
|
作者
Tajdini, Parisa [1 ,2 ]
Foroutan, Majid [3 ,4 ]
机构
[1] Semnan Univ Med Sci, Sch Med, Dept Pediat, Semnan, Iran
[2] Semnan Univ Med Sci, Amir Al Momenin Educ Res & Therapeut Hosp, Clin Res Dev Unit, Semnan, Iran
[3] Semnan Univ Med Sci, Dept Internal Med, Semnan, Iran
[4] Semnan Univ Med Sci, Kowsar Educ Res & Therapeut Hosp, Clin Res Dev Unit, Semnan, Iran
来源
JOURNAL OF RENAL INJURY PREVENTION | 2024年 / 13卷 / 01期
关键词
Oncohypertension; High blood pressure; Cancer; Blood pressure; Pathophysiology; Diagnosis; ANTIHYPERTENSIVE TREATMENT; PARANEOPLASTIC SYNDROMES; ONCO-HYPERTENSION; GROWTH-FACTOR; DIAGNOSIS; TARGET; RISK; PHEOCHROMOCYTOMA; CARDIOLOGY; SYSTEM;
D O I
10.34172/jrip.2024.32259
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Oncohypertension is a relatively recent concept that refers to the development of elevated blood pressure in patients with cancer, which is driven by the tumor itself. This review article aims to provide an overview of oncohypertension, including its pathophysiology, clinical implications, diagnostic approaches, and management strategies. The study discusses the association between oncological disorders and hypertension, highlighting the underlying mechanisms responsible for the development of oncohypertension. Furthermore, various diagnostic methods, including imaging techniques and laboratory tests, are discussed in detail. Finally, treatment options for oncohypertension, including both pharmacological and non -pharmacological approaches, are thoroughly reviewed to optimize blood pressure control and improve patient outcomes
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Bone Effects of Anti-Cancer Treatments in 2024
    Teissonniere, Marie
    Point, Mathieu
    Biver, Emmanuel
    Hadji, Peyman
    Bonnelye, Edith
    Ebeling, Peter R.
    Kendler, David
    de Villiers, Tobias
    Holzer, Gerold
    Body, Jean-Jacques
    Fuleihan, Ghada El Hajj
    Brandi, Maria Luisa
    Rizzoli, Rene
    Confavreux, Cyrille B.
    CALCIFIED TISSUE INTERNATIONAL, 2025, 116 (01)
  • [42] Terpenoids' anti-cancer effects: focus on autophagy
    El-Baba, Chirine
    Baassiri, Amro
    Kiriako, Georges
    Dia, Batoul
    Fadlallah, Sukayna
    Moodad, Sara
    Darwiche, Nadine
    APOPTOSIS, 2021, 26 (9-10) : 491 - 511
  • [43] Terpenoids’ anti-cancer effects: focus on autophagy
    Chirine El-Baba
    Amro Baassiri
    Georges Kiriako
    Batoul Dia
    Sukayna Fadlallah
    Sara Moodad
    Nadine Darwiche
    Apoptosis, 2021, 26 : 491 - 511
  • [44] PEG based anti-cancer drug conjugated prodrug micelles for the delivery of anti-cancer agents
    Senevirathne, Suchithra A.
    Washington, Katherine E.
    Biewer, Michael C.
    Stefan, Mihaela C.
    JOURNAL OF MATERIALS CHEMISTRY B, 2016, 4 (03) : 360 - 370
  • [45] Anti-Cancer Agents for Breast Cancer Treatment During Pregnancy
    Berveiller, Paul
    Veyrie, Nicolas
    Rouzier, Roman
    Carbonne, Bruno
    Mir, Olivier
    JOURNAL OF SURGICAL ONCOLOGY, 2011, 104 (05) : 560 - 560
  • [46] Jasmonates - a new family of anti-cancer agents
    Flescher, E
    ANTI-CANCER DRUGS, 2005, 16 (09) : 911 - 916
  • [47] MECHANISM OF MUTAGENICITY OF ANTHRACYCLINE ANTI-CANCER AGENTS
    KLEID, DG
    GOEDDEL, DV
    JOURNAL OF SUPRAMOLECULAR STRUCTURE, 1978, : 90 - 90
  • [48] ANTI-CANCER AGENTS FROM MARINE ORGANISMS
    WEINHEIMER, AJ
    MATSON, JA
    MARTIN, GE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1979, (APR): : 172 - 172
  • [49] Clinical Trials and Approval of Anti-cancer Agents
    Iwasaki, Masaru
    Hinotsu, Shiro
    Katsura, Jun
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 : i65 - i69
  • [50] Combination of photodynamic therapy with anti-cancer agents
    Zuluaga, M. -F.
    Lange, N.
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (17) : 1655 - 1673